The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
He was saying the reason FDA chose that was literally just because how much they could get people to take. It wasn't like an upper end, like anything above that is unsafe. That wasn't the case. I mean, it was just purely cost and compliance, so what they can get into a pill, the amount they can get, and how many pills they can get people to take.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.